Moleculin Biotech sets 1-for-20 reverse stock split for Oct. 20
Tweet Send to a Friend
Moleculin Biotech, Inc. (NASDAQ: MBRX) announced it has filed an amendment to its certificate of incorporation with the Delaware Secretary ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE




